Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:2523-2529

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hempel, A.
Right arrow Articles by Haller, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hempel, A.
Right arrow Articles by Haller, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*POTASSIUM CYANIDE
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Cell biology/structural biology
Right arrow Chronic ischemic heart disease

(Circulation. 1999;99:2523-2529.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Calcium Antagonists Ameliorate Ischemia-Induced Endothelial Cell Permeability by Inhibiting Protein Kinase C

Albrecht Hempel, MD; Carsten Lindschau, PhD; Christian Maasch, PhD; Matthias Mahn, MD; Rostislav Bychkov, PhD; Thomas Noll, PhD; Friedrich C. Luft, MD; Hermann Haller, MD

From the Franz Volhard Clinic and Max Delbrück Center for Molecular Medicine (A.H., C.L., C.M., M.M., R.B., F.C.L., H.H.), Medizinische Fakultät der Charité, Humboldt University of Berlin, and Physiologisches Institut (T.N.), Justus Liebig University, Giessen, Germany.

Correspondence to Hermann Haller, MD, Franz Volhard Clinic, Wiltberg Strasse 50, 13122 Berlin, Germany. E-mail haller{at}fvk-berlin.de

Background—Dihydropyridines block calcium channels; however, they also influence endothelial cells, which do not express calcium channels. We tested the hypothesis that nifedipine can prevent ischemia-induced endothelial permeability increases by inhibiting protein kinase C (PKC) in cultured porcine endothelial cells.

Methods and Results—Ischemia was induced by potassium cyanide/deoxyglucose, and permeability was measured by albumin flux. Ion channels were characterized by patch clamp. [Ca2+]i was measured by fura 2. PKC activity was measured by substrate phosphorylation after cell fractionation. PKC isoforms were assessed by Western blot and confocal microscopy. Nifedipine prevented the ischemia-induced increase in permeability in a dose-dependent manner. Ischemia increased [Ca2+]i, which was not affected by nifedipine. Instead, ischemia-induced PKC translocation was prevented by nifedipine. Phorbol ester also increased endothelial cell permeability, which was dose dependently inhibited by nifedipine. The effects of non–calcium-channel–binding dihydropyridine derivatives were similar. Analysis of the PKC isoforms showed that nifedipine prevented ischemia-induced translocation of PKC-{alpha} and PKC-{zeta}. Specific inhibition of PKC isoforms with antisense oligodeoxynucleotides demonstrated a major role for PKC-{alpha}.

Conclusions—Nifedipine exerts a direct effect on endothelial cell permeability that is independent of calcium channels. The inhibition of ischemia-induced permeability by nifedipine seems to be mediated primarily by PKC-{alpha} inhibition. Anti-ischemic effects of dihydropyridine calcium antagonists could be due in part to their effects on endothelial cell permeability.


Key Words: cells • ischemia • proteins • calcium




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Gaudreault, R. M. Perrin, M. Guo, C. P. Clanton, M. H. Wu, and S. Y. Yuan
Counter Regulatory Effects of PKC{beta}II and PKC{delta} on Coronary Endothelial Permeability
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1527 - 1533.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. Menne, J.-K. Park, R. Agrawal, C. Lindschau, J. T. Kielstein, T. Kirsch, A. Marx, D. Muller, F. H. Bahlmann, M. Meier, et al.
Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers
FASEB J, May 1, 2006; 20(7): 994 - 996.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. C. Brown, K. S. Mark, R. D. Egleton, and T. P. Davis
Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium
Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1045 - C1052.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Lenasi, K. Kohlstedt, B. Fichtlscherer, A. Mulsch, R. Busse, and I. Fleming
Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495
Cardiovasc Res, October 1, 2003; 59(4): 844 - 853.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Yu, I. Morita, K. Shimokado, T. Iwai, and M. Yoshida
Amlodipine Modulates THP-1 Cell Adhesion to Vascular Endothelium via Inhibition of Protein Kinase C Signal Transduction
Hypertension, September 1, 2003; 42(3): 329 - 334.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. C. Brown and T. P. Davis
Calcium Modulation of Adherens and Tight Junction Function: A Potential Mechanism for Blood-Brain Barrier Disruption After Stroke
Stroke, June 1, 2002; 33(6): 1706 - 1711.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Wang, M. Nomura, S. Patan, and J. A. Ware
Inhibition of Protein Kinase C{alpha} Prevents Endothelial Cell Migration and Vascular Tube Formation In Vitro and Myocardial Neovascularization In Vivo
Circ. Res., March 22, 2002; 90(5): 609 - 616.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Gourine, A. Gonon, P.-O. Sjoquist, and J. Pernow
Short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardised myocardium
Cardiovasc Res, July 1, 2001; 51(1): 100 - 107.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. A. Terlouw, R. Masereeuw, F. G. M. Russel, and D. S. Miller
Nephrotoxicants Induce Endothelin Release and Signaling in Renal Proximal Tubules: Effect on Drug Efflux
Mol. Pharmacol., June 1, 2001; 59(6): 1433 - 1440.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. R. Yingst, J. Davis, and R. Schiebinger
Effects of extracellular calcium and potassium on the sodium pump of rat adrenal glomerulosa cells
Am J Physiol Cell Physiol, January 1, 2001; 280(1): C119 - C125.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Fisslthaler, N. Hinsch, T. Chataigneau, R. Popp, L. Kiss, R. Busse, and I. Fleming
Nifedipine Increases Cytochrome P4502C Expression and Endothelium-Derived Hyperpolarizing Factor-Mediated Responses in Coronary Arteries
Hypertension, August 1, 2000; 36(2): 270 - 275.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Wang, M. Nomura, S. Patan, and J. A. Ware
Inhibition of Protein Kinase C{alpha} Prevents Endothelial Cell Migration and Vascular Tube Formation In Vitro and Myocardial Neovascularization In Vivo
Circ. Res., March 22, 2002; 90(5): 609 - 616.
[Abstract] [Full Text] [PDF]